Risks of relapse in patients with acute anterior uveitis

British Journal of Ophthalmology

Volumn 91, Issue 3, 2007, Pages 330-334

  Natkunarajah, M ^a   Kaptoge, S ^b   Edelsten, C ^a  

^a IPSWICH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; MYDRIATIC AGENT; STEROID;

ACUTE ANTERIOR UVEITIS; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECORDING; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPONDYLOARTHROPATHY; SURVIVAL TIME; UVEITIS; ACUTE DISEASE; AGE; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; IRIDOCYCLITIS; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SEX DIFFERENCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SEX FACTORS; UVEITIS, ANTERIOR;

EID: 33947584511     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.083725     Document Type: Article

References (14)

1. Paivonsalo-Hietanen T, Vaahtoranta-Lehtonen H, Tuominen J, et al. Uveitis survey at the University Eye Clinic in Turku. Acta Ophthalmol 1994;72:505-512.
2. Power WJ, Rodriguez A, Pedroza-Seres M, et al. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 1998;105:1646-1651.
3. Rothova A, van Veenendal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987;103:137- 45.
4. Wakefield D, Easter J, Penny R. Clinical features of HLA-B27 anterior uveitis. Aust J Ophthalmol 1984;12:191-96.
5. Tay-Kearney M, Schwam B, Lowder C. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthal 1996;121:47-56.
6. BenEzra D, et al. Investigation. In: BenEzra D, Shigeaki O, Secchi GA, Alio U, eds. Anterior segment intraocular inflammation guidelines. London, UK: Martin Dunitz, 2000:29-37.
7. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
8. Stata survival analysis and epidemiological tables reference manual release 9; Stata Press, Texas, USA; StataCorp LP, 1985- 2005:120-154.
9. Feltkamp TEW. HLA-B27, acute anterior uveitis, and ankylosing spondylitis. Adv Inflamm Res 1985;9:211-6.
10. Norn MS. Endogenous uveitis. II Recurrence rate. Acta Ophthal 1969;47:366-377.
11. Linssen A, Meenken C. Outcomes of HLA-B27 positive and HLA-B27 negative acute anterior uveitis. Am J Ophthalmol 1995;120:351-361.
12. Edmunds L, Elswood J, Calin A. New light on uveitis in ankylosing spondylitis. J Rheumatol 1991;18:50-52.
13. Paivoansalo-Hietanen T, Tuominen J, Matti Saari K. Seasonal variation of endogenous uveitis in south-western Finland. Acta Ophthalmolo Scand 1998;76:599-602.
14. Secchi A. G, Magni M.D, Tognon M.D. A psychosomatic approach to idiopathic recurrences of anterior uveitis. Am J Ophthalmol 1987;104:174-178.